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Structural requirements for anti-oxidant activity of 
calix[n]arenes and their associated anti-bacterial 
activity 
E.K. Stephens,
a
 Y. Tauran,
b
 A.W. Coleman
 b
 and M. Fitzgerald.
a*
Treatment of neural cells with calix[n]arenes featuring 
sulphonate moieties and linked to Ag nanoparticles results 
in reduced reactive species. For gram+ bacteria there is an 
inverse correlation between anti-bacterial activity and ROS 
reduction whereas for gram- bacteria only calix[6]arenes 
bearing O-alkyl sulphonate functions act as ROS inhibitors 
and anti-bacterial agents. 
 Injury to the central nervous system is characterized by altered Ca2+ 
flux and associated increases in reactive species, thought to be 
triggered by excess glutamate release 1, 2. If reactive species are not 
controlled by endogenous anti-oxidants, oxidative stress ensues, and 
this is a feature of traumatic brain and spinal cord injury as well as 
secondary degeneration 3-5. Anti-oxidants have been used in pre-
clinical studies to treat injury to the central nervous system, but new 
agents are needed in order to generate complementary combinations 
of anti-oxidant therapies to control multiple facets of oxidative 
stress3. Furthermore, antioxidants often suffer from lack of solubility 
and resultant poor bioavailability 6, 7, limiting their clinical 
usefulness.   
Calix[4]arenes have been used as therapeutic delivery systems for 
anti-oxidants and have also been shown to have inherent anti-oxidant 
properties 8. As such they have the potential to provide a 
combinatorial anti-oxidant strategy for neurotrauma. The 
sulphonated calix[n]arene derivatives all have solubilities above 
100mM in water making them attractive as therapeutic agents. The 
para-sulphonato-calix[n]arenes are well documented for their 
biological activities, 9 while the silver nanoparticles capped with 
para- and O-sulphonated derivatives have shown interesting anti-
bacterial activities with selective action against gram+ or gram- 
bacteria. 10 
However the structural requirements for anti-oxidant and anti-
bacterial activity are unknown, making elucidation of the 
mechanisms of action problematic. Here we assess the effects of a 
range of calix[n]arene structures on viability and production of 
reactive oxygen species (ROS) by neuronal cells stressed with an 
excitotoxic concentration of glutamate. We also have studied 
possible association between effects on ROS and anti-bacterial 
activity, as the presence of radicals and hence ROS is one of the 
proposed mechanisms for the anti-bacterial action of silver 
nanoparticles 11. 
Calix[n]arenes were synthesized by literature methods, see SI and 
the sulphated cyclodextrin is commercially available. (Scheme 1). 
Calix[n]arenes were linked to Ag nanoparticles (Ag_NP) by direct 
interaction during the reduction of Ag+ to Ag0 (Scheme S1, SI). The 
linking of calix[n]arenes to Ag nanoparticles may reduce the 
strongly negative charge of the calixarene tail groups, thereby aiding 
in membrane penetration and perhaps increasing antioxidant 
efficacy, compared to calix[n]arenes not linked to Ag nanoparticles. 
Scheme 1 SC(n)a, SC(n)b and SC(n)c correspond, respectively, to para-
sulphonatocalix[n]arene, O-propyl sulphonate calix[n]arene and O-propyl 
para-sulphonato-calix[n]arene; with (n) corresponding to the number of 
phenolic units in the macrocycle. C4diP corresponds to calix[4]arene 
dihydroxyphosphonic acid and CD corresponds to sulphated β-cyclodextrin.   
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Toxicity of nanoparticle preparations in biological systems remains 
an ongoing concern. We therefore assessed the effects of the 
calix[n]arene and cyclodextrin preparations on viability of neuronal 
cell that had been stressed with an excitotoxic concentration of 
glutamate, using Pheochromocytoma (PC12) neuronal-like cells. 
Calcein dye was used to selectively stain viable cells. Images were 
taken at 2 locations in triplicate culture wells at each concentration, 
using a Nikon Inverted Fluorescence microscope. Viable cells 
(green) were counted, expressed relative to unit area and mean ± 
S.E.M calculated. Data were assessed using ANOVA with a 
significance value of p ≤ 0.05, using SPSS statistical software 
(IBM). There were no significant differences in PC12 cell viability 
following glutamate stress and treatment with any of the 
calix[n]arene or cyclodextrin preparations at 100 µg mL-1, compared 
to untreated, glutamate stressed control cells (F=1.42, p=0.12). 
Choice of calix[n]arene and cyclodextrin concentration was in line 
with our previously reported studies and higher than concentrations 
previously shown to exhibit antioxidant activity 8. Representative 
images of cells treated with selected preparations demonstrate that 
treated PC12 cells displayed normal morphology, extending small 
neurites (Figure 1). 
Fig. 1 Viability of PC12 cells that have been stressed with 100mM glutamate 
and treated with 100ug/mL of the various calix[n]arene preparations for 1 
hour. Viability was assessed using calcein dye to label live cells and 
representative images of glutamate stressed untreated cells and glutamate 
stressed cells treated with SC4a or AG_NP_SC8c are shown. Quantification 
of viability data are expressed as mean ± S.E.M live cells/ area assessed. 
 
Having established that the calix[n]arene and cyclodextrin 
preparations were not toxic to neural cells at a concentration of 
100µg mL-1, we assessed the effects on the preparations at 1 – 100 
µg mL-1, on intracellular generation of ROS. Fluorescence of the 
reactive dye chloromethyl dichlorodihydro-fluorescein diacetate 
(CM-H2DCFDA) was used to indicate intracellular reactive species. 
Cellular fluorescence was measured on an Enspire multimode plate 
reader using an excitation wavelength of 480 nm and emission 
wavelength of 530 nm (Software version 4.1). Results for each 
experiment were expressed as mean ± S.E.M. arbitrary units of 
fluorescence intensity data for each group of calix[n]arene 
preparations (e.g. SC4 calixarene preparations), and were assessed 
using ANOVA and Dunnett’s post hoc tests with a significance 
value of p ≤ 0.05, using SPSS statistical software.  
 
Fig. 2 Effects of calix[n]arene and cyclodextrin preparations on ROS 
production by glutamate stressed PC12 cells. Cells were stressed with 
100mM glutamate and treated with 1, 10 or 100 µg mL-1 calixarene or 
cyclodextrin preparations. ROS production was quantified using DCFH-DA 
and results expressed as mean ± S.E.M fluorescence intensity (arbitrary 
units): * p<0.05, significantly different from glutamate only control. 
Experiments were conducted 2-3 times and representative results displayed. 
 
Treatment with each concentration of Ag_NP_SC4a resulted in 
significantly reduced ROS production by PC12 cells (F=5.87, 
p≤0.0001: note p value for least effective concentration provided), 
whereas treatments with SC4a not linked to Ag_NP were not 
effective at reducing ROS (p=0.06, Figure 2A). Efficacy of 
Ag_NP_SC4b was similarly dependent on linkage to Ag_NP 
(p=0.001): SC4b alone had no significant effect on ROS (p=0.16). 
In contrast, Ag_NP_SC4c and SC4c were both effective at reducing 
ROS at the tested concentrations (p=0.001, p=0.01 respectively). 
Treatment with the SC6 preparations followed a similar pattern 
(Figure 2B). Reduction of ROS with SC6a required linkage to 
Ag_NPs (F=3.11, p=0.05). However, SC6b and Ag_NP_SC6b were 
both effective at reducing ROS (p=0.001, p=0.001 respectively), as 
were SC6c and Ag_NP_SC6c (p=0.002, p=0.02 respectively). Note 
that there were some concentration dependent effects following 
treatment with the SC6c preparations but differences were minor and 
unlikely to be biologically meaningful. No reductions in ROS were 
detected following treatment with the SC8 calixarene preparations 
regardless of linkage to Ag_NP (F=1.53, p=0.13), or with the C4diP 
or CD preparations (F=0.84, p=0.61). 
Our data demonstrate that the length and orientation of the sulphated 
tail groups on calix[n]arenes, as well as their interaction with 
Ag_NP, impact upon their intrinsic anti-oxidant activity, and that 
cyclodextrins lack anti-oxidant activity at the tested concentrations. 
The highly anionic groups of the calix[n]arenes may reduce 
interactions with the negative exterior of the plasma membrane 9. 
Nanoparticle surface charge is a determining factor of cellular 
uptake 10, 11 and those with cations present on their surface are more 
easily internalised due to electrostatic interactions with the 
negatively charged cell surface. Attachment of calix[4a,4b,6a]arenes 
to silver-capped nanoparticles resulted in reduced intracellular ROS, 
perhaps via Ag cations reducing the negative charge of the 
calix[n]arenes and increasing internalisation within cells. 
Alternatively, the functional groups of the calix[n]arenes may be 
sequestered within the Ag_NP surface (Scheme S1, SI). Differential 
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efficacy was also observed when comparing calix[n]arene 
preparations of the same ring size, but with different tail structures 
present. In the cases of both 4- and 6-moeity ring sizes, the most 
effective structure was that of SC(n)c, which corresponds to 
sulphonic acid groups present above and below the plane of the 
macrocycle. Calix[n]arenes have been shown to selectively associate 
with, 12, 13 and transport 14 various cations present in biological 
systems, readily forming anionic derivatives, although the 
electrostatic interactions are not well understood and are thought to 
vary largely depending on the degree of charge localisation within 
the ions 15. While the antioxidant mechanism of the SC(n)c is not 
known, complex intracellular anionic interactions are likely to be 
involved, as supported by our previous demonstration of antioxidant 
activity of calix[4]arenes that also featured anionic groups above and 
below the ring 8.  The observation that the calix[8]arenes failed to 
reduce ROS production, regardless of concentration or linkage to 
Ag_NP, suggests that there is a size limit, as well as structural 
requirements, to calix[n]arene efficacy, perhaps due to size exclusion 
of the calix[n]arene cup structure or protein binding incompatibility. 
Note that Ag_NP without calixarene capping degrade rapidly, 
limiting any likely biological effects if dissociation occurs16. 
Antioxidant efficacy is often associated with antibacterial activity17, 
but the mechanism and structural requirements of the association are 
as yet unclear. We had previously assessed efficacy of calix[n]arene 
and cyclodextrin capped Ag nanoparticles at inhibiting growth of 
gram + bacteria and gram – bacteria, by measuring cell growth as a 
percentage of growth in untreated cultures (Table 1).10 There exists 
an inverse relation between the antioxidant efficacy of Ag-NPs 
capped by para-sulphonato-calix[n]arenes and Gram+ antibacterial 
activities. Gram – antibacterial activity was significant in the cases 
of SC6b and SC6c and in both cases, associated with the reduction 
of ROS species. Molecules are active with regard to ROS reduction 
as the isolated molecule and also as the capped NPs (Table 1). 
 
Table 1 Summary of antioxidant activity of calix[n]arenes and 
antioxidant and antibacterial activities of calix[n]arene capped silver 
nanoparticles. ROS levels are expressed as a % of values from control. 
Similarly, antibacterial levels are expressed as a % of growth compared 
to an untreated control. The silver nanoparticles showing an inverse 
dependence between their Gram + anti-bacterial and ROS activities are 
highlighted in red. The silver nanoparticles showing a direct association 
between their Gram - anti-bacterial and ROS activities have been 
highlighted in blue. 
Molecule 
ROS 
level 
(%)  
Molecule 
capped on silver 
nanoparticles 
ROS 
level 
(%)  
Gram + 
Bacterial 
growth 
 (%) 
Gram - 
Bacterial 
growth 
 (%) 
SC4a 68 SC4a_Ag_NP 42 81 100 
SC6a 72 SC6a_Ag_NP 61 55 100 
SC8a 93 SC8a_Ag_NP 87 33 99 
SC4b 73 SC4b_Ag_NP 48 97 99 
SC6b 43 SC6b_Ag_NP 53 98 46 
SC8b 102 SC8b_Ag_NP 93 81 89 
SC4c 51 SC4c_Ag_NP 51 99 84 
SC6c 51 SC6c_Ag_NP 49 98 62 
SC8c 101 SC8c_Ag_NP 111  ND*  ND* 
C4diP 88 C4diP_Ag_NP 86  ND*  ND* 
CD  86 CD_Ag_NP 76  ND*  ND* 
ND*: Not Determined 
From the above it is possible to postulate that while the action of 
calix[n]arene capped nanoparticles with regard to gram+ positive 
bacteria involves radical species and is inhibited by ROS reducing 
systems, for gram – bacteria the action is highly specific, involving 
only calix[6]arene derivatives carrying O-alkyl sulphonate groups at 
the phenolic face and is not related to ROS reducing activity. 
 
Conclusion 
Calix[n]arenes featuring sulphonate groups above and/or below 
the plane of the macrocycle have intrinsic anti-oxidant capacity: 
less sulphonated calix[n]arenes require linkage to Ag_NPs to 
achieve similar efficacy. Calix[n]arenes may be used to carry 
additional therapeutic agents to provide a combinatorial anti-
oxidant strategy for treatment of neurotrauma and other 
diseases. Associated antibacterial activity may enhance 
therapeutic potential in certain clinical scenarios featuring 
infection. The mechanism of the anti-bacterial action remains a 
quandary for gram- bacteria. 
 
Notes and references 
a Experimental and Regenerative Neurosciences, School of Animal 
Biology, The University of Western Australia, Crawley, 6009 WA 
Australia: lindy.fitzgerald@uwa.edu.au 
b LMI, CNRS UMR 5615, Université de Lyon 1, Villeurbanne, F69622, 
France: e-mail antony.coleman@adm.univ-lyon1.fr 
 
1.   J. Knoferle, J. C. Koch, T. Ostendorf, U. Michel, V. Planchamp, P. 
Vutova, L. Tonges, C. Stadelmann, W. Bruck, M. Bahr and P. Lingor, Proc 
Natl Acad Sci U S A, 2010, 107, 6064-6069. 
2.   A. J. Kowaltowski, N. C. de Souza-Pinto, R. F. Castilho and A. E. 
Vercesi, Free Radic Biol Med, 2009, 47, 333-343. 
3.   E. D. Hall, R. A. Vaishnav and A. G. Mustafa, Neurotherapeutics, 2010, 
7, 51-61. 
4.   K. M. Carrico, R. A. Vaishnav and E. D. Hall, J Neurotrauma, 2009. 
5.   M. Fitzgerald, C. A. Bartlett, A. R. Harvey and S. A. Dunlop, J 
Neurotrauma, 2010, 27, 439-452. 
6.   G. Bar-Sela, R. Epelbaum and M. Schaffer, Current medicinal chemistry, 
2010, 17, 190-197. 
7.   H. H. Tonnesen and J. Karlsen, Zeitschrift fur Lebensmittel-Untersuchung 
und -Forschung, 1985, 180, 402-404. 
8.   E. James, P. K. Eggers, A. R. Harvey, S. A. Dunlop, M. Fitzgerald, K. A. 
Stubbs and C. L. Raston, Org Biomol Chem, 2013, 11, 6108-6112. 
9.   N. M. Goldenberg and B. E. Steinberg, Cancer research, 2010, 70, 1277-
1280. 
10.   A. Radomski, P. Jurasz, D. Alonso-Escolano, M. Drews, M. Morandi, T. 
Malinski and M. W. Radomski, British journal of pharmacology, 2005, 146, 
882-893. 
11.   Z. G. Yue, W. Wei, P. P. Lv, H. Yue, L. Y. Wang, Z. G. Su and G. H. 
Ma, Biomacromolecules, 2011, 12, 2440-2446. 
12.   D. Diamond and M. A. McKervey, Chemical Society reviews, 1996, 25, 
15-&. 
13.   R. Ludwig and N. T. K. Dzung, Sensors, 2002, 2, 397-416. 
14.   R. M. Izatt, J. D. Lamb, R. T. Hawkins, P. R. Brown, S. R. Izatt and J. J. 
Christensen, J Am Chem Soc, 1983, 105, 1782-1785. 
15.   J. M. Harrowfield, M. I. Ogden, W. R. Richmond, B. W. Skelton and A. 
H. White, J Chem Soc Perk T 2, 1993, 2183-2190. 
16.   S. Boudebbouze, A. W. Coleman, Y. Tauran, H. Mkaouar, F. Perret, A. 
Garnier, A. Brioude, B. Kim, E. Maguin and M. Rhimi, Chem Commun 
(Camb), 2013, 49, 7150-7152. 
17.   B. Uttara, A. V. Singh, P. Zamboni and R. T. Mahajan, Current 
neuropharmacology, 2009, 7, 65-74. 
 
Page 3 of 3 ChemComm
C
he
m
C
om
m
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
21
 N
ov
em
be
r 2
01
4.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ité
 C
la
ud
e 
Be
rn
ar
d 
Ly
on
 o
n 
23
/1
1/
20
14
 2
3:
49
:5
6.
 
View Article Online
DOI: 10.1039/C4CC08576K
